“…The administration of tryptophan to rats at pharmacological doses is associated with a variable hypoglycaemia (Gullino et al, 1955;Mirsky et al, 1956;McDaniel et al, 1973;Smith & Pogson, 1977), inhibition of hepatic gluconeogenesis (Ray et al, 1966;Oravec & Sourkes, 1967;McDaniel et al, 1972;Smith & Pogson, 1977), increased fatty acid synthesis (Sakurai et al, 1973(Sakurai et al, , 1974Miyazawa et al, 1975), increased ribosomal aggregation (Wunner et al, 1966;Baglia et al, 1968;Sidransky et al, 1968), and changes in the total activities of specific enzymes (Greengard et al, 1963;Rosen & Milholland, 1963;Cihak et al, 1973Cihak et al, , 1975Ballard & Hopgood, 1973).…”